Labtician Ophthalmics  

About Labtician

Our Business Advisors

Dan Brazier

Dan Brazier has 33 years of proven business experience with several well recognized consumer marketing, healthcare and pharmaceutical companies. Responsibilities included Canada, the United States and several international fronts.

He has held a variety of senior positions including sales and marketing management, general management, strategic planning, corporate development and executive
management roles.

Most recently Dan served as CEO, President and was also a member of the Board of Directors of Draxis Health. Prior to his appointment as CEO; he served in the office of the President as Chief Operating Officer.

Prior to joining DRAXIS Health he established a specialty products division within a major international pharmaceutical company and led that division through a period of rapid growth.

Dan Brazier holds an honours degree in Commerce, with a double major in both Marketing and Finance.


Line Break

Dan Brazier

John Snisarenko joined Genentech USA Inc. (a member of the Roche Group) in December 2007 as Vice President, Sales & Marketing, LUCENTIS® responsible for all commercial activities within Genentech’s Ophthalmology franchise. As of March 2013, he is heading up the Rheumatology franchise.

Prior to joining Genentech, John was the VP & General Manager, Ophthalmology at Novadaq Technologies, where he led the development and pre-commercial activities for a novel device that had the potential to be used in imaging and treating abnormal vessels in the back of the eye.

A 20-year veteran of the eyecare industry, John also held the position of Vice President and Business Unit Head for Novartis Ophthalmics, responsible for all commercial activities for the Canadian marketplace. Over his fourteen year tenure at Novartis, he developed a sales and marketing strategy for Canada that helped to grow the Novartis ophthalmic pharmaceutical portfolio to the #1 rank in Canada.

John holds a B.Sc. in Biochemistry and an MBA in Marketing and International Business from McGill University.


Line Break